BioNTech SE (BNTX): next trial readout expected around 2027-08-20
Trials that could report in the next 12 months: 1BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything BNTX is running — see methodology.
- 2027-08-20in 52wA Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through… | Phase 4 | Recruitingstill enrolling patients | 2027-08-20 | NCT07730450 |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeut… | Phase 2 | Recruitingstill enrolling patients | NCT04534205 | |
| Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Mali… | Phase 1 | Active Not Recruitingenrolled, still running | NCT06150183 | |
| A Clinical Study of the Anti-cancer Effects of an Investigational Ther… | Phase 3 | Recruitingstill enrolling patients | NCT06340568 | |
| Safety, Preliminary Effectiveness of BNT327, an Investigational Therap… | Phase 2 | Active Not Recruitingenrolled, still running | NCT06449209 | |
| Clinical Trial Evaluating the Safety, Tolerability and Preliminary Eff… | Phase 1 | Recruitingstill enrolling patients | NCT05142189 | |
| A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent G… | Phase 1 | Active Not Recruitingenrolled, still running | NCT05432583 | |
| Safety and Preliminary Effectiveness of BNT327, an Investigational The… | Phase 2 | Active Not Recruitingenrolled, still running | NCT06449222 |
+ 16 more tracked trials
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With C… | Phase 2 | Recruitingstill enrolling patients | NCT06712316 | |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combinati… | Phase 3 | Recruitingstill enrolling patients | NCT06712355 | |
| A Clinical Study to Find the Optimal Dose of an Investigational Treatm… | Phase 1 | Recruitingstill enrolling patients | NCT06827236 | |
| Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigatio… | Phase 2 | Recruitingstill enrolling patients | NCT06841055 | |
| A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus W… | Phase 2 | Active Not Recruitingenrolled, still running | NCT04486378 | |
| A Clinical Study to Investigate the Efficacy and Safety of an Investig… | Phase 1 | Recruitingstill enrolling patients | NCT06892548 | |
| A Clinical Study to Test if an Investigational Treatment Called BNT326… | Phase 1 | Recruitingstill enrolling patients | NCT07070232 | |
| A Clinical Study to Test if an Investigational Treatment Called BNT314… | Phase 1 | Recruitingstill enrolling patients | NCT07079631 | |
| A Clinical Trial to Test if an Investigational Combination Therapy Wit… | Phase 1 | Recruitingstill enrolling patients | NCT07111520 | |
| A First-in-human, Dose Escalation and Indication Expansion Study of BN… | Phase 1 | Recruitingstill enrolling patients | NCT07147348 | |
| ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients Wit… | Phase 3 | Recruitingstill enrolling patients | NCT07173751 | |
| A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-… | Phase 3 | Recruitingstill enrolling patients | NCT07365995 | |
| A Randomized Clinical Trial Investigating the Safety, Reactogenicity, … | Phase 2 | Recruitingstill enrolling patients | NCT07379580 | |
| A Clinical Trial Testing the Safety of Pumitamig (an Investigational D… | Phase 2 | Recruitingstill enrolling patients | NCT07255404 | |
| A Clinical Trial Testing the Safety of the Investigational Drug Pumita… | Phase 2 | Recruitingstill enrolling patients | NCT07297212 | |
| Safety and Preliminary Effectiveness of BNT317, an Investigational The… | Phase 1 | Recruitingstill enrolling patients | NCT06750185 |
Status-change history
Every ClinicalTrials.gov change recorded for BNTX's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is BNTX's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is BNTX's lead program in?
Phase 3 — recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.